Author: Yuan, Lin; Chen, Zhongbin; Song, Shanshan; Wang, Shan; Tian, Chunyan; Xing, Guichun; Chen, Xiaojuan; Xiao, Zhi-Xiong; He, Fuchu; Zhang, Lingqiang
Title: p53 Degradation by a Coronavirus Papain-like Protease Suppresses Type I Interferon Signaling Cord-id: 7c7qkgca Document date: 2015_1_30
ID: 7c7qkgca
Snippet: Infection by human coronaviruses is usually characterized by rampant viral replication and severe immunopathology in host cells. Recently, the coronavirus papain-like proteases (PLPs) have been identified as suppressors of the innate immune response. However, the molecular mechanism of this inhibition remains unclear. Here, we provide evidence that PLP2, a catalytic domain of the nonstructural protein 3 of human coronavirus NL63 (HCoV-NL63), deubiquitinates and stabilizes the cellular oncoprotei
Document: Infection by human coronaviruses is usually characterized by rampant viral replication and severe immunopathology in host cells. Recently, the coronavirus papain-like proteases (PLPs) have been identified as suppressors of the innate immune response. However, the molecular mechanism of this inhibition remains unclear. Here, we provide evidence that PLP2, a catalytic domain of the nonstructural protein 3 of human coronavirus NL63 (HCoV-NL63), deubiquitinates and stabilizes the cellular oncoprotein MDM2 and induces the proteasomal degradation of p53. Meanwhile, we identify IRF7 (interferon regulatory factor 7) as a bona fide target gene of p53 to mediate the p53-directed production of type I interferon and the innate immune response. By promoting p53 degradation, PLP2 inhibits the p53-mediated antiviral response and apoptosis to ensure viral growth in infected cells. Thus, our study reveals that coronavirus engages PLPs to escape from the innate antiviral response of the host by inhibiting p53-IRF7-IFNβ signaling.
Search related documents:
Co phrase search for related documents- lps induce and luciferase reporter: 1, 2
- lps treatment and luciferase activity: 1
- lps treatment and luciferase assay: 1, 2, 3
- lps treatment and luciferase reporter: 1, 2, 3, 4
- luciferase activity and lung carcinoma: 1
- luciferase activity and lung carcinoma cell: 1
- luciferase activity and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- luciferase activity increase and lysis buffer: 1
- luciferase assay and lung carcinoma: 1
- luciferase assay and lung carcinoma cell: 1
- luciferase assay and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- luciferase gene and lysis buffer: 1, 2
- luciferase reporter and lung adenocarcinoma: 1, 2
- luciferase reporter and lung carcinoma: 1, 2
- luciferase reporter and lung carcinoma cell: 1, 2
- luciferase reporter and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date